March 30, 2022

3 min read


We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

As Healio celebrates National Doctors’ Day today, we recognize dedicated physicians we spoke with over the past year about how they are working both in the clinic and beyond to improve allergy, asthma and immunology care.

These exclusive Q&A interviews explore a range of topics, from how COVID-19 and climate change have impacted treatment to cutting-edge immunotherapies and biologics as well as the social determinants of health.

Consistent, timely exposures ‘key’ to infant food allergen introduction

Amanda Cox, MD, FAAAAI, of the Icahn School of Medicine at Mount Sinai, reviews the guidance and research behind the early introduction of allergens in addition to the best feeding practices to ensure infants have a diverse diet. Read more.

Providers can do more to reduce racial disparities in food allergy care

Andrea Pappalardo

As people of color face higher prevalence of food allergy and its comorbidities, Andrea Pappalardo, MD, FAAAAI, of University of Illinois at Chicago, talks about strategies that can narrow gaps in care along with her own experience in a mobile clinic. Read more.

Allergists can take action to address the health impact of climate change

Increased heat, pollution and precipitation will drive increases in allergy and asthma in the coming decades. Joy Hsu, MD, MSc, FAAAAI, of the CDC’s Division of Environmental Science and Practice, outlines the biggest effects of these changes and points to resources that clinicians can use in providing personalized care. Read more.

Study to assess single oral immunotherapy’s ability to treat multiple food allergens

Current oral immunotherapies target individual allergens such as peanuts, whereas ADP101 aims for 15 substances including nuts, seafood and milk. Alladapt’s Dana McClintock, MD, and Ashley Dombkowski, PhD, explain the science behind the treatment. Read more.

Does asthma mitigate the risk for COVID-19?

Monica Kraft

Monica Kraft, MD, of Arizona College of Medicine, details research involving the role of the ACE2 receptor, inflammation, surfactants and other factors and how they impact the odds of experiencing COVID-19. Read more.

Dupilumab may help patients with eosinophilic esophagitis return to ‘normal’ diet

The chronic allergy inflammatory disease has a significant impact on quality of life. Jonathan Spergel, MD, PhD, of Children’s Hospital of Philadelphia, and his colleagues are studying how the biologic can bring the joy of eating back into their patients’ lives. Read more.

Protocol helps kids overcome phobias related to their food allergies

Food allergies are challenging at any age, but the fears that children feel can be overwhelming. Katherine K. Dahlsgaard, PhD, and Megan Lewis, CRNP, of Children’s Hospital of Philadelphia, review strategies that can help kids conquer these fears. Read more.

Algorithm provides ‘holistic view’ of how air pollution contributes to asthma in kids

The Data-driven ExposurE Profile uncovered how trimethylamine, acrylic acid and other toxins drove asthma severities among children in the New York metropolitan area, according to Gaurav Pandey, PhD, and Supinda Bunyavanich, MD, MPH, MPhil, of the Icahn School of Medicine at Mount Sinai. Read more.

How to distinguish between COVID-19 and allergies, sinusitis

Jessica Grayson

When patients present with congestion, rhinorrhea and loss of smell, what should doctors do? Jessica Grayson, MD, of University of Alabama at Birmingham, breaks down the steps that providers need to take to ensure the right diagnosis and care. Read more.

Asthma research study aims to provide education, support to Bronx schools

Marina Reznik, MD, MS, of Albert Einstein College of Medicine and Children’s Hospital at Montefiore, explains how the Asthma-PASS program will be implemented in up to 40 schools to help children and families learn about how they can manage their asthma symptoms. Read more.

National Penicillin Allergy Day spotlights need to reevaluate patients

About 90% to 95% of people who think they have a penicillin allergy really do not have one, keeping them from using this effective antibiotic. Allison C. Ramsey, MD, of the American Academy of Allergy, Asthma & Immunology Adverse Reactions to Drugs, Biologicals and Latex Committee, discusses why those numbers need to come down. Read more.

Which patients with food allergy are candidates for oral immunotherapy?

Douglas H. Jones

Douglas H. Jones, MD, of Global Food Therapy, explains how oral immunotherapy works, its advantages over other forms of treatment and which patients are best suited for treatment as well as other aspects of care that doctors need to know before they offer it in their clinics. Read more.

By admin

Leave a Reply

Your email address will not be published.